Therefore, we suggest that EGF and CD274 are potential drug targets and diagnostic targets for TB, and AKT1, TP53, ARF1 and PRKCZ may be new potential drug targets and diagnostic targets for TB. The gene discussed is EGF; the disease is tuberculosis.